Cerebrospinal Fluid Inflammatory Biomarkers Reflect Clinical Severity in Huntington’s Disease

• Filipe Brogueira Rodrigues,

  Affiliation Huntington’s Disease Centre, Institute of Neurology, University College London, London, United Kingdom

  http://orcid.org/0000-0002-5567-7938

  ⨯
• Lauren M. Byrne,

  Affiliation Huntington’s Disease Centre, Institute of Neurology, University College London, London, United Kingdom

  ⨯
• Peter McColgan,

  Affiliation Huntington’s Disease Centre, Institute of Neurology, University College London, London, United Kingdom

  ⨯
• Nicola Robertson,

  Affiliation Huntington’s Disease Centre, Institute of Neurology, University College London, London, United Kingdom

  ⨯
• Sarah J. Tabrizi,

  Affiliation Huntington’s Disease Centre, Institute of Neurology, University College London, London, United Kingdom

  ⨯
• Henrik Zetterberg,

  Affiliations Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden, Department of Molecular Neuroscience, Institute of Neurology, University College London, London, United Kingdom

  ⨯
• Edward J. Wild

  * E-mail: e.wild@ucl.ac.uk

  Affiliation Huntington’s Disease Centre, Institute of Neurology, University College London, London, United Kingdom

  ⨯